Page last updated: 2024-09-05

erlotinib hydrochloride and as 1411

erlotinib hydrochloride has been researched along with as 1411 in 1 studies

Compound Research Comparison

Studies (erlotinib hydrochloride)	Trials (erlotinib hydrochloride)	Recent Studies (post-2010) (erlotinib hydrochloride)	Studies (as 1411)	Trials (as 1411)	Recent Studies (post-2010) (as 1411)
4,353	786	3,033	182	2	167

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Hu, X; Jeevithan, E; Mariadoss, AVA; Saravanakumar, K; Sathiyaseelan, A; Shin, S; Wang, MH	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and as 1411

Article	Year
Dual stimuli-responsive release of aptamer AS1411 decorated erlotinib loaded chitosan nanoparticles for non-small-cell lung carcinoma therapy. Carbohydrate polymers, 2020, Oct-01, Volume: 245 Topics: A549 Cells; Animals; Apoptosis; Aptamers, Nucleotide; Carcinoma, Non-Small-Cell Lung; Cell Survival; Chitosan; Drug Carriers; Drug Liberation; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Nanoparticles; NIH 3T3 Cells; Oligodeoxyribonucleotides; Reactive Oxygen Species; Signal Transduction	2020

Article

Year

Dual stimuli-responsive release of aptamer AS1411 decorated erlotinib loaded chitosan nanoparticles for non-small-cell lung carcinoma therapy.

Carbohydrate polymers, 2020, Oct-01, Volume: 245

Topics: A549 Cells; Animals; Apoptosis; Aptamers, Nucleotide; Carcinoma, Non-Small-Cell Lung; Cell Survival; Chitosan; Drug Carriers; Drug Liberation; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Nanoparticles; NIH 3T3 Cells; Oligodeoxyribonucleotides; Reactive Oxygen Species; Signal Transduction

2020